Cognition and fatigue in patients with relapsing multiple sclerosis treated by subcutaneous interferon β-1a: an observational study SKORE

Sleep and Cognitive Function in Multiple Sclerosis

(2016) Tiffany J. Braley et al.   SLEEP

Sleep and Cognitive Function in Multiple Sclerosis

(2016) Tiffany J. Braley et al.   SLEEP

Searching for the neural basis of reserve against memory decline: intellectual enrichment linked to larger hippocampal volume in multiple sclerosis

(2015) J. F. Sumowski et al.   EUROPEAN JOURNAL OF NEUROLOGY

Staying on the job: The relationship between work performance and cognition in individuals diagnosed with multiple sclerosis

(2015) Brandon C. Baughman et al.   JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY

Factors influencing long-term outcomes in relapsing–remitting multiple sclerosis: PRISMS-15

(2015) Ludwig Kappos et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Cognitive reserve moderates the impact of subcortical gray matter atrophy on neuropsychological status in multiple sclerosis

(2015) Claire M Modica et al.   Multiple Sclerosis Journal

Cognitive reserve moderates the impact of subcortical gray matter atrophy on neuropsychological status in multiple sclerosis

(2015) Claire M Modica et al.   Multiple Sclerosis Journal

Cognitive Reserve as a Useful Concept for Early Intervention Research in Multiple Sclerosis

(2015) James F. Sumowski   Frontiers in Neurology

The Multiple Sclerosis Functional Composite: A clinically meaningful measure of disability

(2015) C. H. Polman et al.   NEUROLOGY

Small non-coding RNA signature in multiple sclerosis patients after treatment with interferon-β

(2014) Bruna De Felice et al.   BMC Medical Genomics

Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis

(2014) Sandra Meyer-Moock et al.   BMC Neurology

Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis

(2014) Masaaki Niino et al.   BMC Neurology

Higher Education Moderates the Effect of T2 Lesion Load and Third Ventricle Width on Cognition in Multiple Sclerosis

(2014) Daniela Pinter et al.   PLoS One

The Dopaminergic System in Autoimmune Diseases

(2014) Rodrigo Pacheco et al.   Frontiers in Immunology

Dopamine Receptor D3 Expressed on CD4+ T Cells Favors Neurodegeneration of Dopaminergic Neurons during Parkinson's Disease

(2013) H. Gonzalez et al.   JOURNAL OF IMMUNOLOGY

Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT

(2013) G. Edan et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Neural Correlates of Cognitive Fatigue: Cortico-Striatal Circuitry and Effort–Reward Imbalance

(2013) Ekaterina Dobryakova et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Subcutaneous Interferon β-1a May Protect against Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study

(2013) Francesco Patti et al.   PLoS One

Grey matter damage in multiple sclerosis

(2013) Roel Klaver et al.   Prion

Adrenergic and Dopaminergic Modulation of Immunity in Multiple Sclerosis: Teaching Old Drugs New Tricks?

(2012) Marco Cosentino et al.   Journal of Neuroimmune Pharmacology

Cognitive reserve and patient-reported outcomes in multiple sclerosis

(2012) Carolyn E Schwartz et al.   Multiple Sclerosis Journal

Dopaminergic Modulation of CD4+CD25high Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-ß Therapy

(2012) Marco Cosentino et al.   NEUROIMMUNOMODULATION

Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis

(2012) K. A. Rahn et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Neurobiological studies of fatigue

(2012) Mary E. Harrington   PROGRESS IN NEUROBIOLOGY

Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control

(2011) Roshan Cools et al.   BIOLOGICAL PSYCHIATRY

Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study

(2011) Stefano Bastianello et al.   BMC Neurology

Cognition in multiple sclerosis

(2011) Dawn W Langdon   CURRENT OPINION IN NEUROLOGY

Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis

(2011) Sonia Batista et al.   JOURNAL OF NEUROLOGY

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis

(2011) Douglas S Goodin et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial

(2011) Giancarlo Comi et al.   LANCET NEUROLOGY

Risk factors for and management of cognitive dysfunction in multiple sclerosis

(2011) Ralph H. B. Benedict et al.   Nature Reviews Neurology

Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients

(2010) Ranjan Dutta et al.   ANNALS OF NEUROLOGY

Cognitive deficits in multiple sclerosis: a systematic review

(2010) Maria Lúcia Brito Ferreira   ARQUIVOS DE NEURO-PSIQUIATRIA

PRISMS: the story of a pivotal clinical trial series in multiple sclerosis

(2010) Bruce A. Cohen et al.   CURRENT MEDICAL RESEARCH AND OPINION

Multiple sclerosis-associated fatigue

(2010) Lauren B Krupp et al.   Expert Review of Neurotherapeutics

Fatigue and Cognition in Patients with Relapsing Multiple Sclerosis Treated with Interferon Beta

(2010) Maria Melanson et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Frequency of cognitive impairment dramatically increases during the first 5 years of multiple sclerosis

(2010) F. Reuter et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study

(2010) Maria P Amato et al.   Multiple Sclerosis Journal

The contribution of MRI in assessing cognitive impairment in multiple sclerosis

(2010) M. Filippi et al.   NEUROLOGY

Fatigue and processing speed are related in multiple sclerosis

(2009) A. K. Andreasen et al.   EUROPEAN JOURNAL OF NEUROLOGY

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

(2009) Ludwig Kappos et al.   LANCET NEUROLOGY

Effects of immunomodulatory treatment with subcutaneous interferon beta-1a oncognitive decline in mildly disabled patients with relapsing—remitting multiple sclerosis

(2009) F. Patti et al.   Multiple Sclerosis Journal

Therapy with interferon-β modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis

(2008) Mauro Zaffaroni et al.   EXPERIMENTAL NEUROLOGY

In vivo MR imaging of hippocampal lesions in multiple sclerosis

(2008) Stefan D. Roosendaal et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Memory decline evolves independently of disease activity in MS

(2008) B Duque et al.   Multiple Sclerosis Journal

Cognitive impairment in multiple sclerosis

(2008) F Patti   Multiple Sclerosis Journal